Despite treatment with current standard of care, patients with CKD and T2D havehigh residual cardiorenal morbidity and mortality.6,60,67, -69 Efforts have been made toassess risk based on an individual’s eGFR and albumin-to-creatinine ratio (eg,the heat map included in the KDIGO CKD guidelines).70 Hemodynamic factors,metabolic factors, and inflammation and fibrosis are key drivers of CKDprogression in T2D. Here, ALB is linked to type 2 diabetes mellitus.